BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, January 16, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Dec. 10, 2025

Dec. 10, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cytovale, Mediwound, OM1, Prelude.
Read More

In the clinic for Dec. 9, 2025

Dec. 9, 2025
Clinical updates, including data readouts and publications: AL-S, Arcellx, Ascletis, Biomx, Cerevance, Deciphera, Disc, Dyne, Encoded, Galapagos, GRI, Immix, Innovent, Kymera, Neurona, Prime, Puretech, Sensorion, Star, Vivacta, Wave Life.
Read More

In the clinic for Dec. 9, 2025

Dec. 9, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: GC Genome, Lucid Diagnostics, Paragonix, Saga Diagnostics.
Read More

In the clinic for Dec. 9, 2025

Dec. 9, 2025
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Eisai, Immvira, Impact, Kelun-Biotech, Mabwell, Tramscenta.
Read More

In the clinic for Dec. 8, 2025

Dec. 8, 2025
Clinical updates, including data readouts and publications: Amneal, Amylyx, Biogen, Cantargia, Cervomed, CG, Galimedix, Impact, Oric, Praxis, Rapport, Stoke, Transcenta, Zhittya.
Read More

In the clinic for Dec. 8, 2025

Dec. 8, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Neuropace.
Read More

In the clinic for Dec. 5, 2025

Dec. 5, 2025
Clinical updates, including data readouts and publications: Apellis, Bioage, Bioarctic, Estrella, Immvira, Pliant, Sobi.
Read More

In the clinic for Dec. 4, 2025

Dec. 4, 2025
Clinical updates, including data readouts and publications: ADC, Biogen, Black Diamond, BMS, Capricor, Clene, Eisai, Elevar, Iliad, Lantern, Muvon, Nuvation, Onco3r, Oncotelic, Pharvaris, Quadriga.
Read More

In the clinic for Dec. 4, 2025

Dec. 4, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: BTT, BTT Medical Institute, Dariohealth, Delcath, Endra, Famenity, Owkin, Sunbird Bio.
Read More

In the clinic for Dec. 3, 2025

Dec. 3, 2025
Clinical updates, including data readouts and publications: Cervomed, Eisai, Enterome, Fennec, Gen, Imvax, Janux, Jasper, Longeveron, Mabwell, Orbus, Pacira, Vaderis, Vandria.
Read More
Previous 1 2 3 4 5 6 7 8 9 … 313 314 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 15, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Businesswoman pressing dollar sign on touchscreen

    JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

    BioWorld
    It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing